Sheikh Mohammad Fazle Akbar Selected Research

DNA (Deoxyribonucleic Acid)

12/2021	The Safety and Efficacy of a Therapeutic Vaccine for Chronic Hepatitis B: A Follow-Up Study of Phase III Clinical Trial.
1/2020	Hepatitis B Core-related Antigen: An Alternative to Hepatitis B Virus DNA to Assess Treatment Eligibility in Africa.
1/2019	Genomic analysis of Hepatitis B virus and its association with disease manifestations in Bangladesh.
1/2018	Poor Sensitivity of Commercial Rapid Diagnostic Tests for Hepatitis B e Antigen in Senegal, West Africa.
6/2014	Genome-wide study of hypomethylated and induced genes in patients with liver cancer unravels novel anticancer targets.
1/2013	Discovery and validation of DNA hypomethylation biomarkers for liver cancer using HRM-specific probes.
1/2012	Biochemical, virological, immunological and histopathological features of 702 incidentally detected chronic hepatitis B virus carriers in Bangladesh.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sheikh Mohammad Fazle Akbar Research Topics

Disease

23	Chronic Hepatitis B 07/2023 - 01/2010
9	Infections 09/2023 - 01/2010
7	Hepatitis B 06/2021 - 06/2011
4	COVID-19 03/2023 - 12/2020
4	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 07/2012
3	Fibrosis (Cirrhosis) 07/2022 - 01/2012
3	Non-alcoholic Fatty Liver Disease 07/2022 - 08/2010
3	Acute-On-Chronic Liver Failure 01/2022 - 11/2017
3	Liver Diseases (Liver Disease) 01/2020 - 06/2010
2	Hepatitis 07/2023 - 09/2022
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019 - 06/2011
2	Neoplasms (Cancer) 06/2014 - 01/2013
2	Chronic Hepatitis (Chronic Active Hepatitis) 01/2013 - 06/2010
2	Inflammation (Inflammations) 01/2012 - 06/2011
1	Fatty Liver 07/2022
1	Insulin Resistance 07/2022
1	Coronavirus Infections 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018
1	Neuroinflammatory Diseases 01/2018
1	Alzheimer Disease (Alzheimer's Disease) 01/2018
1	Hepatitis C 11/2017
1	Hyponatremia 11/2017
1	Hepatorenal Syndrome 11/2017
1	Renal Insufficiency (Renal Failure) 11/2017
1	End Stage Liver Disease 11/2017
1	Cysts 01/2015
1	Obesity 01/2015
1	Urinary Bladder Neoplasms (Bladder Cancer) 06/2014
1	Neoplasm Metastasis (Metastasis) 06/2014
1	Melanoma (Melanoma, Malignant) 01/2013
1	Liver Neoplasms (Liver Cancer) 01/2013

Drug/Important Bio-Agent (IBA)

16	VaccinesIBA 07/2023 - 01/2010
14	Hepatitis B Surface Antigens (HBsAg)FDA Link 09/2023 - 01/2010
12	Antiviral Agents (Antivirals)IBA 07/2023 - 01/2010
9	Hepatitis B Core AntigensIBA 05/2023 - 08/2010
9	AntigensIBA 01/2020 - 01/2010
7	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 01/2012
5	Alanine Transaminase (SGPT)IBA 07/2022 - 01/2011
4	Hepatitis B e AntigensIBA 01/2020 - 06/2011
3	Hepatitis B Vaccines (Hepatitis B Vaccine)IBA 09/2023 - 06/2010
3	InterferonsIBA 05/2023 - 07/2012
3	Ivermectin (Mectizan)FDA Link 04/2021 - 12/2020
3	CytokinesIBA 01/2020 - 08/2010
2	Biomarkers (Surrogate Marker)IBA 01/2013 - 06/2011
1	AntibodiesIBA 09/2023
1	obeticholic acidIBA 07/2022
1	LigandsIBA 07/2022
1	Telbivudine FDA Link 06/2021
1	Tenofovir (Viread)FDA Link 06/2021
1	gamma- hydroxy- gamma- ethyl- gamma- phenylbutyramide (HEPB)IBA 04/2021
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2020
1	Amyloid (Amyloid Fibrils)IBA 01/2018
1	Nucleic AcidsIBA 01/2018
1	Immunoglobulin M (IgM)IBA 11/2017
1	Immunoglobulin G (IgG)IBA 11/2017
1	Cytidine Triphosphate (CTP)IBA 11/2017
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2017
1	Macrophage Colony-Stimulating FactorIBA 01/2016
1	CCR2 ReceptorsIBA 01/2016
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2016
1	Drinking WaterIBA 01/2015
1	Proteins (Proteins, Gene)FDA Link 06/2014
1	Small Interfering RNA (siRNA)IBA 06/2014
1	Therapeutic UsesIBA 08/2013
1	Immunoglobulins (Immunoglobulin)IBA 01/2013
1	Fc Receptors (Fc Receptor)IBA 01/2013
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2013
1	DNA PrimersIBA 07/2012

Therapy/Procedure

11	Therapeutics 07/2023 - 06/2010
2	Investigational Therapies (Experimental Therapy) 05/2022 - 06/2011
2	Immunotherapy 01/2016 - 07/2013
1	Aftercare (After-Treatment) 05/2023
1	Secondary Prevention 01/2022
1	Plasma Exchange 01/2022